296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 260 institutions

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

Authors

Showing 5 results for author "Sobha Sivaprasad".

Back to authors

Thumbnail for Avacincaptad Pegol Reduces Progression of Ellipsoid Zone Loss and Degradation in Eyes With the Highest Baseline Ellipsoid Zone Burden

P143

Avacincaptad Pegol Reduces Progression of Ellipsoid Zone Loss and Degradation in Eyes With the Highest Baseline Ellipsoid Zone Burden

Sobha Sivaprasad, Katherine E. Talcott, Reem Amine, Karen Matar, Asmita Indurkar, Amy Tang, Lyndsey DellaVecchia, Hasan Cetin, John Mamone, Jamie Reese, Don Luo, Dan Luo, Dina Abulon, Justis...

The Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA, Astellas Pharma Inc., Northbrook, IL, USA, Moorf...

Poster Presenter: Sobha Sivaprasad

Thumbnail for Early�Real-World�Effectiveness and�Safety of�Faricimab in�Eyes�With�Retinal�Vein�Occlusion (RVO):�3-Month�Results�From�the UK FARWIDE-RVO�Study

P157

Early�Real-World�Effectiveness and�Safety of�Faricimab in�Eyes�With�Retinal�Vein�Occlusion (RVO):�3-Month�Results�From�the UK FARWIDE-RVO�Study

Christine Kiire, Deepali Varma, Sobha Sivaprasad, Ian Pearce, James Talks, Richard Gale, Louise Downey, Gloria Chi, Abigail Darnell, Melanie Dodds, Parul Dayal

Genentech, Inc., South San Francisco, CA, USA, Roche Products Ltd., Welwyn Garden City, UK, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK, South Tyneside and Sunderland NHS Foundation Trust...

RCOphth Annual Congress 2026

Authors

Avacincaptad Pegol Reduces Progression of Ellipsoid Zone Loss and Degradation in Eyes With the Highest Baseline Ellipsoid Zone Burden

Early�Real-World�Effectiveness and�Safety of�Faricimab in�Eyes�With�Retinal�Vein�Occlusion (RVO):�3-Month�Results�From�the UK FARWIDE-RVO�Study

Proportions of CVIs in England attributable to four major causes before, during and after the COVID pandemic

THULITE, a Phase II, randomised, double-masked, placebo-controlled trial of BI 1815368 in patients with centre-involved diabetic macular edema: Study design

Two-year Effectiveness, Durability and Safety of Faricimab in Eyes With Diabetic Macular Oedema: Results From the UK FARWIDE-DMO Study